ArticlePloS one2025
Disability-adjusted life years associated with COVID-19 in Brazil, 2020.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Seroprevalence, immune response dynamics, and incidence of COVID-19 after CoronaVac vaccination in a fully vaccinated small municipality in Northeast Brazil: a population-based surveillance study.BMC infectious diseases · 2026Observational
- Metropolitan inequalities in health system resources and COVID-19 adjusted life expectancy among older adults in Mexico.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe quantified the national- and state-level burden of COVID-19 in Brazil and its states during 2020 and contrasted it to the burden from other causes of disease and injury.
methodsWe used national surveillance data on COVID-19 cases, hospitalisations and deaths between February/2020 to December/2020. We calculated disability-adjusted life years (DALYs) based on the COVID-19 consensus model and methods developed by the European Burden of Disease Network, which includes mild to moderate, severe, and critical COVID-19 cases, long covid and deaths due to COVID-19. We used Brazil DALYs estimates from the Global Burden of Disease Collaborative Network to compare the COVID-19 burden to that from other causes of disease and injury.
resultsCOVID-19's led to 5,445,785 DALYs, or 2,603 DALYs/100,000, with > 99% of the burden caused by mortality. Males accounted for the largest fraction of DALYs (3,214,905 or 59%) and DALYs per 100,000 population (140,594 or 63%). Most populated states experienced the highest DALYs. However, the DALYs per 100,000 population were higher in the states of Rio de Janeiro (4,504 DALYs/100,000), Amapá (4,106 DALYs/100,000) and Roraima (3,981 DALYs/100,000). Assuming no major changes in disease burden from other causes of disease and injury from 2019 to 2020 in Brazil, COVID-19's burden would rank as the leading cause of disability in 2020.
conclusionsCompared with studies with similar methodology, our findings showed that Brazil experienced the highest COVID-19 burden (per 100,000 population) in the world. COVID-19 severely impacted Brazil's populational health in 2020, highlighting the lack of effective mitigation efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.